Antiproliferative effects of sapacitabine (CYC682), a novel 2'-deoxycytidine-derivative, in human cancer cells
about
Sapacitabine for cancerInduction of cytotoxicity, apoptosis and cell cycle arrest by 1-t-butyl carbamoyl, 7-methyl-indole-3-ethyl isothiocyanate (NB7M) in nervous system cancer cells.Cellular pharmacology of multi- and duplex drugs consisting of ethynylcytidine and 5-fluoro-2'-deoxyuridine.Spectrum of cellular responses to pyriplatin, a monofunctional cationic antineoplastic platinum(II) compound, in human cancer cellsDevelopment of an oral form of azacytidine: 2'3'5'triacetyl-5-azacytidine.Nucleic Acid Bioconjugates in Cancer Detection and Therapy.Bone Marrow and Peripheral Blood AML Cells Are Highly Sensitive to CNDAC, the Active Form of SapacitabineA coumarin derivative (RKS262) inhibits cell-cycle progression, causes pro-apoptotic signaling and cytotoxicity in ovarian cancer cells.Isothiocyanate NB7M causes selective cytotoxicity, pro-apoptotic signalling and cell-cycle regression in ovarian cancer cells.New nucleoside analogs for patients with hematological malignancies.Profile of sapacitabine: potential for the treatment of newly diagnosed acute myeloid leukemia in elderly patients.Microwave-assisted synthesis of 2(1H)-pyridones and their glucosides as cell proliferation inhibitors.Laparoscopic subperitoneal injection of chemo-loaded particles lowers tumor growth on a rabbit model of peritoneal carcinomatosis.A randomised comparison of the novel nucleoside analogue sapacitabine with low-dose cytarabine in older patients with acute myeloid leukaemia.
P2860
Q27024675-D21BA52E-B7ED-4860-A79F-E56DB8392DB8Q33516119-FF70DA4E-C425-4B5F-9083-5E30FA3959BAQ34567805-69B3D1C7-E689-4CDF-8D2F-842C7B602CB9Q35206753-435E123D-BA20-4187-99FA-8FE722ED4547Q35687461-D20B94F5-0583-47FC-B66B-30FFDC862D38Q35867875-AD01A523-4501-4D89-BBD3-E7FA32C7A3D3Q36289307-C6C969D8-FA24-4C83-98CE-0728D37918ACQ36711125-E5B31003-420C-4462-B373-944374F3CB7FQ37010601-B2E268B7-4457-4C41-B90B-EA8F5534F59BQ37841589-E4661ED7-C1AD-4354-8BF1-E7E3B47EEC8FQ38213704-90B9971E-36DB-4ECD-A4A5-BACF4ADF3CBBQ39584369-F059B8BB-7A9A-4206-B3D0-22DE9C0F230FQ50894767-42690A26-41CB-4DBA-A401-3AF0A3405F0CQ53618653-8763B7F2-925C-44E4-9C1A-8873CBC547A4
P2860
Antiproliferative effects of sapacitabine (CYC682), a novel 2'-deoxycytidine-derivative, in human cancer cells
description
2007 nî lūn-bûn
@nan
2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Antiproliferative effects of s ...... ivative, in human cancer cells
@ast
Antiproliferative effects of s ...... ivative, in human cancer cells
@en
Antiproliferative effects of s ...... ivative, in human cancer cells
@nl
type
label
Antiproliferative effects of s ...... ivative, in human cancer cells
@ast
Antiproliferative effects of s ...... ivative, in human cancer cells
@en
Antiproliferative effects of s ...... ivative, in human cancer cells
@nl
prefLabel
Antiproliferative effects of s ...... ivative, in human cancer cells
@ast
Antiproliferative effects of s ...... ivative, in human cancer cells
@en
Antiproliferative effects of s ...... ivative, in human cancer cells
@nl
P2093
P2860
P356
P1476
Antiproliferative effects of s ...... ivative, in human cancer cells
@en
P2093
C Le Tourneau
C M Galmarini
E Cvitkovic
K Benhadji
P2860
P2888
P304
P356
10.1038/SJ.BJC.6603896
P407
P577
2007-09-03T00:00:00Z
P5875
P6179
1010559546